is a Venture Partner in the London-based venture capital firm Advent Venture Partners and a Fellow of the Judge Business School at the University of Cambridge. At an earlier stage in his career he co-founded two biotechnology companies, Medarex Inc., and Genmab A/S, both of which focus on monoclonal antibody therapeutics. Under his leadership Medarex raised more than a billion dollars and spun off Genmab, which subsequently completed the largest biotechnology IPO in the history of European capital markets up to the time of the offering. Dr Drakeman, who received his J.D. from Columbia and his PhD from Princeton in the field of religion, practiced law in the State of New York in earlier years and also taught at Princeton, with which he continues to be associated in his capacity as Chairman of the Advisory Council of the James Madison Program in American Ideals and Institutions. In 2010 Cambridge University Press published Church, State, and Original Intent, his monograph devoted to the establishment clause of the First Amendment to the Constitution of the United States. His most recent book, Why We Need the Humanities, was published in 2016.
